Safety and immunogenicity of a replication deficient simian adenoviral vectored chikungunya vaccine: A phase I, first-in-human, dose escalation trial
Huvudupphovsmän: | , , , , , , , , , , , , , , , , , |
---|---|
Materialtyp: | Conference item |
Språk: | English |
Publicerad: |
American Society of Tropical Medicine and Hygiene
2019
|